BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 38158908)

  • 1. [Eosinophilic chronic obstructive pulmonary disease: A review].
    Anaev EK
    Ter Arkh; 2023 Oct; 95(8):696-700. PubMed ID: 38158908
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular markers of type 2 airway inflammation are similar between eosinophilic severe asthma and eosinophilic chronic obstructive pulmonary disease.
    Fricker M; McDonald VM; Winter NA; Baines KJ; Wark PAB; Simpson JL; Gibson PG
    Allergy; 2021 Jul; 76(7):2079-2089. PubMed ID: 33470427
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship between Blood and Induced Sputum Eosinophils, Bronchial Hyperresponsiveness and Reversibility of Airway Obstruction in Mild-to-Moderate Chronic Obstructive Pulmonary Disease.
    Proboszcz M; Mycroft K; Paplinska-Goryca M; Górska K; Nejman-Gryz P; Jankowski P; Zak N; Krenke R
    COPD; 2019 Dec; 16(5-6):354-361. PubMed ID: 31631716
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Eosinophils in COPD-Current Concepts and Clinical Implications.
    Mycroft K; Krenke R; Górska K
    J Allergy Clin Immunol Pract; 2020 Sep; 8(8):2565-2574. PubMed ID: 32251737
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Eosinophilic endotype of chronic obstructive pulmonary disease: similarities and differences from asthma.
    Li A; Chan HP; Gan PXL; Liew MF; Wong WSF; Lim HF
    Korean J Intern Med; 2021 Nov; 36(6):1305-1319. PubMed ID: 34634855
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Blood eosinophils in COPD: friend or foe?
    Papaporfyriou A; Bakakos P; Hillas G; Papaioannou AI; Loukides S
    Expert Rev Respir Med; 2022 Jan; 16(1):35-41. PubMed ID: 34821191
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Eicosanoids and Eosinophilic Inflammation of Airways in Stable COPD.
    Celejewska-Wójcik N; Kania A; Górka K; Nastałek P; Wójcik K; Gielicz A; Mastalerz L; Sanak M; Sładek K
    Int J Chron Obstruct Pulmon Dis; 2021; 16():1415-1424. PubMed ID: 34079245
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeted therapy in eosinophilic chronic obstructive pulmonary disease.
    Fieldes M; Bourguignon C; Assou S; Nasri A; Fort A; Vachier I; De Vos J; Ahmed E; Bourdin A
    ERJ Open Res; 2021 Apr; 7(2):. PubMed ID: 33855061
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-IL-5 therapies for chronic obstructive pulmonary disease.
    Donovan T; Milan SJ; Wang R; Banchoff E; Bradley P; Crossingham I
    Cochrane Database Syst Rev; 2020 Dec; 12(12):CD013432. PubMed ID: 33295032
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Eosinophilic and Neutrophilic Airway Inflammation in the Phenotyping of Mild-to-Moderate Asthma and Chronic Obstructive Pulmonary Disease.
    Górska K; Paplińska-Goryca M; Nejman-Gryz P; Goryca K; Krenke R
    COPD; 2017 Apr; 14(2):181-189. PubMed ID: 27983888
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peripheral blood eosinophils: a surrogate marker for airway eosinophilia in stable COPD.
    Negewo NA; McDonald VM; Baines KJ; Wark PA; Simpson JL; Jones PW; Gibson PG
    Int J Chron Obstruct Pulmon Dis; 2016; 11():1495-504. PubMed ID: 27445469
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The association between airway eosinophilic inflammation and IL-33 in stable non-atopic COPD.
    Tworek D; Majewski S; Szewczyk K; Kiszałkiewicz J; Kurmanowska Z; Górski P; Brzeziańska-Lasota E; Kuna P; Antczak A
    Respir Res; 2018 Jun; 19(1):108. PubMed ID: 29859068
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Blood Eosinophils as Biomarkers to Drive Treatment Choices in Asthma and COPD.
    Kostikas K; Brindicci C; Patalano F
    Curr Drug Targets; 2018; 19(16):1882-1896. PubMed ID: 29437007
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [COPD and eosinophils].
    Gueçamburu M; Zysman M
    Rev Mal Respir; 2022 Oct; 39(8):685-697. PubMed ID: 36055950
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Eosinophilic airway inflammation in COPD.
    Saha S; Brightling CE
    Int J Chron Obstruct Pulmon Dis; 2006; 1(1):39-47. PubMed ID: 18046901
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Eosinophilic inflammation in chronic obstructive pulmonary disease].
    Avdeev SN; Trushenko NV; Merzhoeva ZM; Ivanova MS; Kusraeva EV
    Ter Arkh; 2019 Oct; 91(10):144-152. PubMed ID: 32598645
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Blood and Sputum Eosinophils of COPD Patients Are Differently Polarized than in Asthma.
    Mycroft K; Paplińska-Goryca M; Proboszcz M; Nejman-Gryz P; Krenke R; Górska K
    Cells; 2023 Jun; 12(12):. PubMed ID: 37371101
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Monoclonal antibody therapy for the treatment of asthma and chronic obstructive pulmonary disease with eosinophilic inflammation.
    Nixon J; Newbold P; Mustelin T; Anderson GP; Kolbeck R
    Pharmacol Ther; 2017 Jan; 169():57-77. PubMed ID: 27773786
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Benralizumab for chronic obstructive pulmonary disease and sputum eosinophilia: a randomised, double-blind, placebo-controlled, phase 2a study.
    Brightling CE; Bleecker ER; Panettieri RA; Bafadhel M; She D; Ward CK; Xu X; Birrell C; van der Merwe R
    Lancet Respir Med; 2014 Nov; 2(11):891-901. PubMed ID: 25208464
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Eosinophilic airway inflammation: role in asthma and chronic obstructive pulmonary disease.
    George L; Brightling CE
    Ther Adv Chronic Dis; 2016 Jan; 7(1):34-51. PubMed ID: 26770668
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.